102 related articles for article (PubMed ID: 38724174)
1.
Maas EJ; DeBortoli E; Nathan V; Freeman NP; Mothershaw A; Smit DJ; Betz-Stablein B; Aoude LG; Stark MS; Sturm RA; Soyer HP; McInerney-Leo AM
J Med Genet; 2024 May; ():. PubMed ID: 38724174
[No Abstract] [Full Text] [Related]
2. MITF E318K: A rare homozygous case with multiple primary melanoma.
Wallingford CK; Maas EJ; Howard A; DeBortoli E; Bhanja D; Lee K; Mothershaw A; Jagirdar K; Willett R; Betz-Stablein B; Sturm RA; Soyer HP; McInerney-Leo AM
Pigment Cell Melanoma Res; 2024 Jan; 37(1):68-73. PubMed ID: 37635363
[TBL] [Abstract][Full Text] [Related]
3. The interplay of sun damage and genetic risk in Australian multiple and single primary melanoma cases and controls.
McMeniman EK; Duffy DL; Jagirdar K; Lee KJ; Peach E; McInerney-Leo AM; De'Ambrosis B; Rayner JE; Smithers BM; Soyer HP; Sturm RA
Br J Dermatol; 2020 Aug; 183(2):357-366. PubMed ID: 31794051
[TBL] [Abstract][Full Text] [Related]
4. Histologic features of melanoma associated with germline mutations of CDKN2A, CDK4, and POT1 in melanoma-prone families from the United States, Italy, and Spain.
Sargen MR; Calista D; Elder DE; Massi D; Chu EY; Potrony M; Pfeiffer RM; Carrera C; Aguilera P; Alos L; Puig S; Elenitsas R; Yang XR; Tucker MA; Landi MT; Goldstein AM
J Am Acad Dermatol; 2020 Sep; 83(3):860-869. PubMed ID: 32283231
[TBL] [Abstract][Full Text] [Related]
5. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
Duffy DL; Lee KJ; Jagirdar K; Pflugfelder A; Stark MS; McMeniman EK; Soyer HP; Sturm RA
Br J Dermatol; 2019 Nov; 181(5):1009-1016. PubMed ID: 30820946
[TBL] [Abstract][Full Text] [Related]
6. Multiple primary melanomas versus single melanoma of the head and neck: a comparison of genetic, diagnostic, and therapeutic implications.
Pollio A; Tomasi A; Pellacani G; Ruini C; Mandel VD; Fortuna G; Seidenari S; Ponti G
Melanoma Res; 2014 Jun; 24(3):267-72. PubMed ID: 24638154
[TBL] [Abstract][Full Text] [Related]
7. Targeted germline sequencing of patients with three or more primary melanomas reveals high rate of pathogenic variants.
Li C; Liu T; Tavtigian SV; Boucher K; Kohlmann W; Cannon-Albright L; Grossman D
Melanoma Res; 2020 Jun; 30(3):247-251. PubMed ID: 31567591
[TBL] [Abstract][Full Text] [Related]
8. On naevi and melanomas in dysplastic naevus syndrome patients.
Crijns MB; Bergman W; Berger MJ; Hermans J; Sober AJ
Clin Exp Dermatol; 1993 May; 18(3):248-52. PubMed ID: 8348718
[TBL] [Abstract][Full Text] [Related]
9. Association of germline variants in telomere maintenance genes (
Goldstein AM; Qin R; Chu EY; Elder DE; Massi D; Adams DJ; Harms PW; Robles-Espinoza CD; Newton-Bishop JA; Bishop DT; Harland M; Holland EA; Cust AE; Schmid H; Mann GJ; Puig S; Potrony M; Alos L; Nagore E; Millán-Esteban D; Hayward NK; Broit N; Palmer JM; Nathan V; Berry EG; Astiazaran-Symonds E; Yang XR; Tucker MA; Landi MT; Pfeiffer RM; Sargen MR
JAAD Int; 2023 Jun; 11():43-51. PubMed ID: 36876055
[TBL] [Abstract][Full Text] [Related]
10. Melanoma-prone families: new evidence of distinctive clinical and histological features of melanomas in CDKN2A mutation carriers.
Gironi LC; Colombo E; Pasini B; Giorgione R; Farinelli P; Zottarelli F; Esposto E; Zavattaro E; Allara E; Ogliara P; Betti M; Dianzani I; Savoia P
Arch Dermatol Res; 2018 Dec; 310(10):769-784. PubMed ID: 30218143
[TBL] [Abstract][Full Text] [Related]
11. Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in ACD,
Pastorino L; Andreotti V; Dalmasso B; Vanni I; Ciccarese G; Mandalà M; Spadola G; Pizzichetta MA; Ponti G; Tibiletti MG; Sala E; Genuardi M; Chiurazzi P; Maccanti G; Manoukian S; Sestini S; Danesi R; Zampiga V; La Starza R; Stanganelli I; Ballestrero A; Mastracci L; Grillo F; Sciallero S; Cecchi F; Tanda ET; Spagnolo F; Queirolo P; Italian Melanoma Intergroup (IMI) ; Goldstein AM; Bruno W; Ghiorzo P
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32325837
[TBL] [Abstract][Full Text] [Related]
12. Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomas.
Kakavand H; Crainic O; Lum T; O'Toole SA; Kefford RF; Thompson JF; Wilmott JS; Long GV; Scolyer RA
Pathology; 2014 Apr; 46(3):193-8. PubMed ID: 24614711
[TBL] [Abstract][Full Text] [Related]
13. Germline Variants in the POT1-Gene in High-Risk Melanoma Patients in Austria.
Müller C; Krunic M; Wendt J; von Haeseler A; Okamoto I
G3 (Bethesda); 2018 May; 8(5):1475-1480. PubMed ID: 29523635
[TBL] [Abstract][Full Text] [Related]
14. Associations of pigmentary and naevus phenotype with melanoma risk in two populations with comparable ancestry but contrasting levels of ambient sun exposure.
Cust AE; Drummond M; Bishop DT; Azizi L; Schmid H; Jenkins MA; Hopper JL; Armstrong BK; Aitken JF; Kefford RF; Giles GG; Demenais F; Goldstein AM; Barrett JH; Kanetsky PA; Elder DE; Mann GJ; Newton-Bishop JA
J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1874-1885. PubMed ID: 31087403
[TBL] [Abstract][Full Text] [Related]
15. Melanoma with benign melanocytic naevus components: reappraisal of clinicopathological features and prognosis.
Kaddu S; Smolle J; Zenahlik P; Hofmann-Wellenhof R; Kerl H
Melanoma Res; 2002 Jun; 12(3):271-8. PubMed ID: 12140384
[TBL] [Abstract][Full Text] [Related]
16. A
Abu Shtaya A; Kedar I; Bazak L; Basel-Salmon L; Barhom SF; Naftali M; Eskin-Schwartz M; Birk OS; Polager-Modan S; Keidar N; Reznick Levi G; Levi Z; Yablonski-Peretz T; Mahamid A; Segol O; Matar R; Bareli Y; Azoulay N; Goldberg Y
Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540414
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.
Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG
Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957
[TBL] [Abstract][Full Text] [Related]
18. POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.
Potrony M; Puig-Butille JA; Ribera-Sola M; Iyer V; Robles-Espinoza CD; Aguilera P; Carrera C; Malvehy J; Badenas C; Landi MT; Adams DJ; Puig S
Br J Dermatol; 2019 Jul; 181(1):105-113. PubMed ID: 30451293
[TBL] [Abstract][Full Text] [Related]
19. A new POT1 germline mutation-expanding the spectrum of POT1-associated cancers.
Wilson TL; Hattangady N; Lerario AM; Williams C; Koeppe E; Quinonez S; Osborne J; Cha KB; Else T
Fam Cancer; 2017 Oct; 16(4):561-566. PubMed ID: 28389767
[TBL] [Abstract][Full Text] [Related]
20. Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma.
Wong K; Robles-Espinoza CD; Rodriguez D; Rudat SS; Puig S; Potrony M; Wong CC; Hewinson J; Aguilera P; Puig-Butille JA; Bressac-de Paillerets B; Zattara H; van der Weyden L; Fletcher CDM; Brenn T; Arends MJ; Quesada V; Newton-Bishop JA; Lopez-Otin C; Bishop DT; Harms PW; Johnson TM; Durham AB; Lombard DB; Adams DJ
JAMA Dermatol; 2019 May; 155(5):604-609. PubMed ID: 30586141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
